Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
DETROIT Congressional leaders this week asked heads of four of the nation’s largest pharmaceutical companies to pledge to marketing practices — in particular direct-to-consumer ads — that could reduce misleading and deceptive prescription drug advertising.
U.S. Reps. John Dingell, D-Mich., and Bart Stupak, D-Mich., sent letters dated Tuesday to pharma heavyweights Merck, Pfizer, Schering-Plough and Johnson & Johnson. The letters request that the companies adhere to guidelines, including:
– “To not market products in DTC advertisements until a valid outcomes study of the product is completed and results are released.”
–
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in